Ian Wiid

2.1k total citations
50 papers, 1.6k citations indexed

About

Ian Wiid is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Ian Wiid has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 26 papers in Molecular Biology and 21 papers in Epidemiology. Recurrent topics in Ian Wiid's work include Tuberculosis Research and Epidemiology (27 papers), Mycobacterium research and diagnosis (17 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (9 papers). Ian Wiid is often cited by papers focused on Tuberculosis Research and Epidemiology (27 papers), Mycobacterium research and diagnosis (17 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (9 papers). Ian Wiid collaborates with scholars based in South Africa, India and United States. Ian Wiid's co-authors include Paul D. van Helden, Svetoslav Dimitrov Todorov, Bienyameen Baker, Shaheen Mehtar, Gina Leisching, A J Bester, Eileen G. Hoal, Gillian A. Wallis, C. D. Boyd and Anne Grobler and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Ian Wiid

50 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Wiid South Africa 23 697 536 399 207 196 50 1.6k
Markus Nagl Austria 30 866 1.2× 541 1.0× 446 1.1× 143 0.7× 470 2.4× 117 2.8k
Tetsuya Iida Japan 24 1.3k 1.9× 431 0.8× 295 0.7× 200 1.0× 99 0.5× 45 2.5k
Fengjun Sun China 27 999 1.4× 259 0.5× 215 0.5× 197 1.0× 105 0.5× 104 2.2k
Salvador Said‐Fernández Mexico 24 536 0.8× 498 0.9× 270 0.7× 205 1.0× 260 1.3× 117 1.9k
Yiqun Deng China 35 1.4k 2.0× 398 0.7× 223 0.6× 185 0.9× 118 0.6× 115 3.0k
Israr Khan Pakistan 18 1.3k 1.9× 272 0.5× 207 0.5× 202 1.0× 108 0.6× 78 2.2k
Sadhna Sharma India 30 708 1.0× 600 1.1× 368 0.9× 119 0.6× 177 0.9× 88 2.6k
Mohammad Azhar Kamal Saudi Arabia 22 586 0.8× 394 0.7× 253 0.6× 141 0.7× 61 0.3× 65 1.8k
Małgorzata Polz‐Dacewicz Poland 24 469 0.7× 189 0.4× 238 0.6× 112 0.5× 262 1.3× 127 1.7k
Ayako Miyazaki Japan 31 614 0.9× 967 1.8× 196 0.5× 142 0.7× 251 1.3× 158 2.9k

Countries citing papers authored by Ian Wiid

Since Specialization
Citations

This map shows the geographic impact of Ian Wiid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Wiid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Wiid more than expected).

Fields of papers citing papers by Ian Wiid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Wiid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Wiid. The network helps show where Ian Wiid may publish in the future.

Co-authorship network of co-authors of Ian Wiid

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Wiid. A scholar is included among the top collaborators of Ian Wiid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Wiid. Ian Wiid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wiid, Ian, et al.. (2019). The role of low molecular weight thiols in Mycobacterium tuberculosis. Tuberculosis. 116. 44–55. 17 indexed citations
2.
Tabb, David L., et al.. (2018). Proteomic analysis reveals that sulfamethoxazole induces oxidative stress in M. tuberculosis. Tuberculosis. 111. 78–85. 12 indexed citations
3.
Leisching, Gina, et al.. (2017). RNAseq Reveals Hypervirulence-Specific Host Responses to M. tuberculosis Infection. 4(2). 3 indexed citations
4.
Leisching, Gina, Ian Wiid, & Bienyameen Baker. (2017). The Association of OASL and Type I Interferons in the Pathogenesis and Survival of Intracellular Replicating Bacterial Species. Frontiers in Cellular and Infection Microbiology. 7. 196–196. 45 indexed citations
5.
Leisching, Gina, et al.. (2016). The Host Response to a Clinical MDR Mycobacterial Strain Cultured in a Detergent-Free Environment: A Global Transcriptomics Approach. PLoS ONE. 11(4). e0153079–e0153079. 30 indexed citations
6.
Leisching, Gina, et al.. (2016). Virulence, biochemistry, morphology and host-interacting properties of detergent-free cultured mycobacteria: An update. Tuberculosis. 100. 53–60. 22 indexed citations
7.
Wiid, Ian, et al.. (2015). Effect of milk fermentation by kefir grains and selected single strains of lactic acid bacteria on the survival of Mycobacterium bovis BCG. International Journal of Food Microbiology. 217. 170–176. 13 indexed citations
8.
Baker, Bienyameen, Mark F. Cotton, Anneke C. Hesseling, et al.. (2012). Sulfamethoxazole enhances the antimycobacterial activity of rifampicin. Journal of Antimicrobial Chemotherapy. 67(12). 2908–2911. 22 indexed citations
9.
Wiid, Ian, Paul D. van Helden, Baojie Wan, et al.. (2011). Novel thiolactone–isatin hybrids as potential antimalarial and antitubercular agents. Bioorganic & Medicinal Chemistry Letters. 21(7). 2055–2058. 35 indexed citations
10.
Kidd, Martin, et al.. (2010). Glutamate dehydrogenase and glutamine synthetase are regulated in response to nitrogen availability in Myocbacterium smegmatis. BMC Microbiology. 10(1). 138–138. 57 indexed citations
11.
Onajole, Oluseye K., Patrick Govender, Paul D. van Helden, et al.. (2009). Pentacyclo-undecane derived cyclic tetra-amines: Synthesis and evaluation as potent anti-tuberculosis agents. European Journal of Medicinal Chemistry. 44(11). 4297–4305. 31 indexed citations
13.
Sirgel, Frederick A., Ian Wiid, & Paul D. van Helden. (2008). Measuring Minimum Inhibitory Concentrations in Mycobacteria. Methods in molecular biology. 465. 173–186. 28 indexed citations
14.
Todorov, Svetoslav Dimitrov, Marelize Botes, Claudia Guigas, et al.. (2007). Boza, a natural source of probiotic lactic acid bacteria. Journal of Applied Microbiology. 0(0). 3642482533–???. 161 indexed citations
15.
Mehtar, Shaheen, Ian Wiid, & Svetoslav Dimitrov Todorov. (2007). The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the Western Cape: an in-vitro study. Journal of Hospital Infection. 68(1). 45–51. 157 indexed citations
16.
Hesseling, Anneke C., H. Simon Schaaf, Thomas C. Victor, et al.. (2004). Resistant Mycobacterium bovis Bacillus Calmette-Gu??rin Disease : Implications for Management of Bacillus Calmette-Gu??rin Disease in Human Immunodeficiency Virus-Infected Children. The Pediatric Infectious Disease Journal. 23(5). 476–479. 33 indexed citations
17.
Wiid, Ian, et al.. (2004). Differential Expression of Mycothiol Pathway Genes: Are they Affected by Antituberculosis Drugs?. IUBMB Life. 56(3). 131–138. 14 indexed citations
18.
Loots, Du Toit, Ian Wiid, Benedict J. Page, Lodewyk J. Mienie, & Paul D. van Helden. (2004). Melatonin prevents the free radical and MADD metabolic profiles induced by antituberculosis drugs in an animal model. Journal of Pineal Research. 38(2). 100–106. 22 indexed citations
19.
Wiid, Ian, et al.. (1988). Cross-contamination of human esophageal squamous carcinoma cell lines detected by DNA fingerprint analysis.. PubMed. 48(20). 5660–2. 29 indexed citations
20.
Wiid, Ian, Glenda Durrheim, A J Bester, & Paul D. van Helden. (1988). Structural alterations in chromatin during myogenesis in the chicken. Molecular and Cellular Biochemistry. 79(1). 57–62. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026